A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma

Clinical trial NCT06642792 · RECRUITING

Trial details

NCT number: NCT06642792
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Classic Hodgkin Lymphoma

Start date: 2025-01-17
Primary completion: 2027-11-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.